Planet 13 - Earnings Call - Q1 2025
May 14, 2025
Executive Summary
- Q1 2025 revenue was $28.0M, down sequentially from $30.3M in Q4 2024 and below S&P Global consensus of $30.5M*, driven by pricing pressure and softer tourism; management highlighted cost alignment and efficiency initiatives to stabilize margins.
- Gross margin compressed to 42.8% from 43.2% in Q4 and 51.9% in Q3, reflecting industry-wide pricing pressure, though Florida cultivation upgrades are expected to reduce discounting and support margin recovery.
- Net loss improved year-over-year to $2.0M from $5.9M; Adjusted EBITDA was a loss of $2.5M versus breakeven in Q4, with lower operating leverage cited as the driver.
- Strategic catalysts: continued Florida retail expansion (Port Richey, Orange Park, Edgewater) and a ~$10.5M recovery related to the El Capitan matter, supporting liquidity and operational focus in core markets.
What Went Well and What Went Wrong
What Went Well
- Management reinforced brand differentiation and entertainment-led retail strategy as resilience drivers amid macro headwinds: “our differentiated brands and focus on entertainment continue to drive relative outperformance” – Co-CEO Larry Scheffler.
- Net loss improved to $2.0M from $5.9M YoY, and total liabilities decreased slightly versus year-end, indicating measured financial discipline.
- Florida cultivation upgrades beginning to improve product quality, expected to reduce discounting and expand gross margins in that market – CFO Dennis Logan.
What Went Wrong
- Revenue missed consensus and declined sequentially; management cited seasonality, consumer weakness, and persistent pricing pressure across Nevada, California, and Illinois.
- Gross margin fell to 42.8% from 51.9% in Q3 and 43.2% in Q4 due to industry-wide price compression; Adjusted EBITDA turned to a $2.5M loss on lower operating leverage.
- Operating expenses rose year-over-year (Florida integration), and management is pursuing SG&A cost concessions (professional, audit, tax fees) to counter margin pressure.
Transcript
Operator (participant)
Please stand by. Good day, everyone, and welcome to the Planet 13 Q1 2025 financial results conference call. Just a reminder, today's call is being recorded. At this time, I would like to hand the call over to Mr. Mark Kuindersma. Please go ahead, sir.
Mark Kuindersma (Head of Investor Relations)
Thank you. Good afternoon, everyone, and thanks for joining us today. Planet 13 Holdings' first quarter 2025 financial results will be released today. The press release to the company's quarterly report, time cue being the MD&A and financial statements, are available on the SEC website, EDGAR and SEDAR Plus, as well as on our website, planet13.com. Before I pass the call over to management, I'd like to remind listeners that portions of today's discussion include forward-looking statements. The forward-looking statements in this conference call are made as of the date of this call. There can be no assurances that such information will prove to be accurate, that management's expectations or estimates of future developments, circumstances, or results will materialize. Risk factors that could affect results are detailed in the company's public filing that are made available with the United States Securities and Exchange Commission and on SEDAR Plus.
We encourage listeners to read those statements in conjunction with today's call. As a result of these risks and concerns, the results are uncertain, predicting these forward-looking statements may differ materially from actual results or events. Transition will occur to both GAAP and non-GAAP financial measures. Information regarding our non-GAAP financial measures and reconciliation to the most directly comparable GAAP measures. Please refer to today's press release posted on our website. Planet 13 financial statements are presented in U.S. dollars, and the results discussed during this call are in U.S. dollars unless otherwise indicated. On the call today are Larry Scheffler, Co-Chairman and Co-CEO, Bob Groesbeck, Co-Chairman and Co-CEO, and Dennis Wilman, CFO. I will now pass the call over to Larry Scheffler, Co-Chairman and Co-CEO of Planet 13. Larry, go ahead.
Larry Scheffler (Co-Chairman and Co-CEO)
Hello, everyone, and welcome. We appreciate you taking the time to be with us. I'll start with a look at our operational performance before handing things over to Dennis for a deep dive into our financials. Bob will then take you through how we're adapting and executing on our strategy in today's volatile environment. In Q1 2025, the superstore, including Dazed!, delivered $11.2 million in revenue. Q1 was a challenging quarter in Las Vegas, with our visitor volume, per the Las Vegas Visitors Authority, reported down 7% year-over-year, in what is already a seasonably low part of the year. This translates into cannabis sales statewide for all operators down 9% year-over-year, with a disproportionate impact on the Las Vegas area. Despite the broader headwinds, our teams executed with discipline.
Our diversified product mix, uniquely unique celebrity-focused products and events, and superior location are helping us defend our market share. Revenue from our neighborhood store network came in at $13.4 million, reflecting a 5% sequential decline from Q4, largely driven by seasonal trends. Declines in Nevada, California, and Illinois were offset by encouraging growth in Florida. This is early signs of the impact we're seeing from the upgrades and improvements we started making late last year. These new cultivation rooms are producing significantly improved flower, quality, potency, and yield, which is fundamental to us, regaining the market share in Florida, a core priority to us. Across the superstore and our neighborhood network, total retail revenue reached $24.6 million compared to $26.9 million in Q4 2024. While this market is certainly challenging, we are pleased with our relative performance, especially in our core states in Nevada and Florida.
We generated $3.4 million from wholesale in Q1, consistent with $3.4 million in Q4. In a quarter where both our wholesale markets were down over 3% sequentially, this is a strong performance illustrative of the difference of our branded products in Nevada. Our performance was led by our Medizin and HaHa brands, with both which both saw strong growth year-over-year. In addition, we augmented our popular in-house brands with celebrity brands that have significant built-in customer following, like Khalifa Kush. In California, our performance is driven by our ability to flex a low-cost cultivation facility in California to maximize our yields. While consumer softness and industry-wide price compression continue to pressure the market, we remain confident in our ability to execute. Backed by commitment to product quality and brand strength, excuse me, we are taking proactive measures to adapt, innovate, and reinforce our leadership in this dynamic environment.
With that, I'll turn it over to Dennis to walk through our financials.
Dennis Wilman (CFO)
Thank you, Larry. In Q1 2025, Planet 13 generated $28 million in revenue, up from $22.9 million in revenue in Q1 2024 and down from the $30.3 million we generated in Q4 2024. The sequential decline mimics what happened across most of our markets, with Nevada, California, and Illinois being down sequentially, driven by seasonality, consumer weakness, and persistent pricing pressure. The year-over-year increase was the result of the inclusion of revenue from our acquisition of VidaCann, which closed in May of 2024 and was not included in our Q1 2024 results. Looking forward, we expect the operating landscape to remain volatile, shaped by sustained competition and pricing pressure that will likely continue to affect top-line performance. Industry dynamics are being further disrupted by the growing prevalence of intoxicating hemp products and ongoing illicit market activity, particularly in California and Nevada.
These challenges are compounded by the notable decline in tourism in Las Vegas and heightened competitive activity in Florida. Gross profit was $12 million in Q1 2025 compared to $13.1 million in Q4 of 2024. This translates into a gross margin of 42.8% in the quarter compared to 43.2% in Q4 of 2024. Gross margin continues to be under pressure industry-wide, driven by price compression across all markets, with price down for equivalent grams on average of around 5% year-over-year. On the positive side, we are seeing improved product quality coming out of our Florida cultivation facility from the recently completed upgrades. This will help us reduce the amount of discounting in the state and drive gross margin expansion for us across our store network. Sales and marketing expense increased marginally to $1.5 million in Q1, up from $1.4 million in Q4.
The increase in expenditures can be attributed to specific marketing actions in Nevada, along with costs associated with transferring the VidaCann website and e-commerce platforms to the Planet 13 platform. G&A was down marginally from $14.1 million in Q4 to $14 million in Q1 2025. At the end of the quarter, we initiated a comprehensive cost-saving program aimed at driving long-term operational efficiency and preserving cash in the more challenging macro environment that we're in. These efforts span across our organization and include streamlining our supply chain, renegotiating and consolidating vendor relationships, reducing discretionary spending, and optimizing our workforce structure. While some of these actions have resulted in near-term restructuring costs, we expect to realize meaningful savings over the next several quarters. Revenue deleveraging we saw this quarter, ahead of the actions we have taken to right-size the costs, resulted in adjusted EBITDA loss of $2.5 million.
Our goal is to rectify this in the quarters to come by aligning our costs and focusing on our most productive and profitable assets. Turning to the balance sheet, as of March 31, 2025, the company had a cash balance of $17.6 million. In addition, as part of the El Capitan lawsuit, we have a property that we are in the act of selling that is currently valued on our balance sheet at just over $4.5 million. We are significantly slowing our CapEx plans for the year as we've largely reached the retail footprint in Florida that we are happy with. As of the quarter end, we had approximately $10 million in short-term debt outstanding, and subsequent to the quarter, we successfully refinanced $5 million in notes payable originally due April 1, 2025, under the terms of the VidaCann acquisition agreement with our local banking partner.
With reduced capital expenditure requirements, greater flexibility in our debt obligations, and a company-wide cost reduction initiative underway, we are sharply focused on improving cash flow and strengthening our balance sheet. With that, I'll turn the call over to Bob to discuss the steps we are taking that will focus on profitability.
Bob Groesbeck (Co-Chairman and Co-CEO)
Thank you, Dennis, and good afternoon, everyone. We enter 2025 with a realistic view of volatility in the cannabis market. The consumer environment remains challenging, as mentioned earlier, pressured by macroeconomic uncertainty, price compression, and an increasingly competitive landscape across many of our markets. Yet we've seen these cycles before. This team has proven it can navigate turbulence, make the tough decisions, and emerge stronger. That's exactly what we're doing. The cannabis industry is evolving quickly, and we're evolving with it. We are executing a focused, disciplined strategy centered on profitability, operational efficiency, and free cash flow generation, starting with our two core markets, Florida and Nevada. We're conducting a full bottom-up review of our portfolio, state by state, asset by asset, dispensary by dispensary. This is a comprehensive realignment effort with a clear mandate: optimize margins, enhance efficiency, and improve returns on every dollar of capital deployed.
Since the end of Q1, we've already taken decisive steps to right-size our cost structure, aligning with current revenue levels and market realities. We're driving greater accountability and visibility across every layer of the business from corporate overhead to cultivation operation. At the same time, we are doubling down on what is working: our profitable core markets of Florida and Nevada. Florida continues to be our most important growth and profitability engine. In Q1, we expanded our retail footprint by opening three new dispensaries, increasing our market reach to cover the majority of the state's population. At the same time, we completed a major upgrade of our cultivation and manufacturing infrastructure. The improvements in yield and potency from our enhanced cultivation rooms have exceeded our expectations, boosting THC content and improving grams per square foot.
These enhancements are already translating to improved competitiveness, reduced reliance on promotional pricing, and healthier gross margins. The next unlock is our investment in targeted automation, particularly in post-harvest processing and packaging, to improve throughput and cost efficiency. These upgrades will allow us to better match our SKU mix to consumer demand, including broader size formats for flower, pre-roll, and vape cartridges. Everything we're doing in Florida, whether it's expanding retail, upgrading infrastructure, or improving product mix, is focused on one thing: generating more cash from every dollar of revenue. Turning to Nevada, our other core market, we remain focused on maximizing cash flow and sustaining our leadership position in a competitive retail environment. Our partnerships with celebrity and entertainment brands continue to differentiate us and attract new customers.
We are actively leveraging these alliances to deepen loyalty and capture incremental market share while optimizing costs across our dispensaries and cultivation facilities. We're balancing our tourist-focused offering, which dominates Thursday through Sunday, with a more local-focused offering mixed during the rest of the week, prioritizing what matters to our everyday shoppers: good products at low prices. Across the company, our operating mantra is simple: do more with less. While these changes won't yield results overnight, we are confident that they will materially improve our profitability and cash flow profile over the coming quarters. We remain disciplined in capital allocation, focused on cash flow, and committed to building a leaner, more resilient business. As the year progresses, we expect to return to profitability led by a rationalization of assets, enhanced cultivation yields, tighter cost control, and smarter retail execution. We are not chasing growth for growth's sake.
We are prioritizing durable, capital-efficient performance. To our employees, we want to say thank you for your resilience and commitment during this period of transformation. To our customers and patients, we remain dedicated to delivering high-quality cannabis products and outstanding service. To our shareholders, we appreciate your continued trust as we execute our plan to drive long-term value for the company. I again want to thank everybody for participating today. I'll now turn it over to the operator and open the line for questions from covering analysts.
Operator (participant)
Thank you, sir. Everyone, if you have a question, it's star one on your telephone keypad. We will take a question from Frederico Gomes, ATB Capital Markets.
Frederico Gomes (Director of Institutional Research and Life Sciences)
Hi, good evening. Thanks for taking my questions. First question on your cash flows, negative operating cash flow this quarter, obviously a very tough environment. Do you expect to turn positive cash flow from operations through the year? How do you see that progressing? If you could help us understand the drivers here that will take you there. Thank you.
Bob Groesbeck (Co-Chairman and Co-CEO)
Thanks, Fred. Thanks for the question. Dennis?
Dennis Wilman (CFO)
Yeah, no, we do anticipate being cash flow positive operationally, obviously excluding any 280E tax payments, you know, held with filing. Take that out of the equation. We are reducing costs at the retail level, wholesale level, at the cultivation level, as well as rationalizing our overall cost structure and trying to deliver more with less. We are making progress. April was promising as we instituted these changes. I think we're aiming to be cash positive from operations for Q2, Q3 for sure. Our goal is Q2. You know, kind of going forward, we are laser-focused on minimizing any planned CapEx. As we said, we've got the store network in Florida fully built out to where we want it to be.
We have one upgrade in Florida that we're working on, but largely all the remaining CapEx in our other markets are finished and finalized. That's sort of the plan going forward for the year.
Frederico Gomes (Director of Institutional Research and Life Sciences)
Got it. Thanks for that. Second question on your Nevada position. I can see that you decided to not move forward with that. Can you talk about why, you know, what drove that decision?
Dennis Wilman (CFO)
It was really we were from a technical perspective in the discussions. I don't want to get into the detail on it, but suffice to say, we contractually didn't meet the conditions that we put into the acquisition agreement. Given the way the market had gone to, we decided that it was in our best interest at that point to not renegotiate the acquisition. The Nevada market, as Larry indicated, has been very challenging. Q1 more so than usual with the sequential declines in visitors in an already slow seasonal period. I think we made the right decision there, saving that cash on a balance sheet for operations and going forward in Florida. Focusing on existing operations in Nevada and our Florida network as the main focus.
Frederico Gomes (Director of Institutional Research and Life Sciences)
Perfect. Final question for me here. How should we think about the assets that you have, the operations that you have in California and Illinois, given that they do not look like they are core assets? How should we think about that in terms of profitability and your strategy regarding those two states? Thanks.
Dennis Wilman (CFO)
Bob, do you want to take that one or do you want me to keep going?
Bob Groesbeck (Co-Chairman and Co-CEO)
Yeah, let me jump in. Yeah, thank you. Yeah, that's kind of, you know, as I indicated in my comments, that's part of our comprehensive review of all of our business units, including California. California has been a drag for quite some time on the balance sheet. It's a very difficult market, very challenging. There are some bright spots there. You know, we're not married to anything. Moving forward, if they're not making money for the company, then we're going to look at alternatives. California is not unique in that respect. Same with Illinois. We're taking a very deep dive to see what fits within the portfolio as we move forward.
Frederico Gomes (Director of Institutional Research and Life Sciences)
Perfect. Appreciate it, caller. Thank you.
Operator (participant)
The next question is from Pablo Zuanic, Zuanic & Associates.
Pablo Zuanic (Managing Partner)
Thank you. Good afternoon, everyone. Just understand better in the case of Florida, what's the upside here going forward? It seems that you're going to stop at 33 stores, but you have all these cultivation improvements that are coming through. Can you put a number on that in terms of, you know, are you expanding rooms? Do you still have room to improve yields? You know, are we talking about a doubling of output, a 50% increase? If you can try to quantify that. Related to that, at what point do you start rolling in more brands from your portfolio in Florida, or has that already happened? Thank you.
Bob Groesbeck (Co-Chairman and Co-CEO)
Let me jump in. Dennis, you can get a little more detail with Pablo, and Pablo did it already. Yeah, on the brand side, we are moving brands into the market now. We've seen a lot of our genetics, you know, have now gone through the system. We've received approvals from OMMU. Recently, for instance, we just got our Dreamland product lines approved. We are moving ahead aggressively to start getting products to the shelves. It's a slow process down there. You certainly know, it takes a long time to get approvals. We are comfortable with the strain mix that's coming in. We brought a lot of genetics in from Nevada that are adapting quite well to that grow environment.
You know, the cultivation side of it, as we said, and Dennis can talk more to the specifics, but, you know, these were substantial improvements to multiple rooms with the latest state-of-the-art LED lighting, cooling and environmental control. We are seeing substantial increases in not only potency, but yield. We are very excited about that because, you know, we did not have that last year. We are starting now. We are in a position where we can actually, you know, feed the store network with quality products consistently. We are not running out like we were last year. A lot of upside there. Again, you know, integrating the new stores into the Planet 13 family has been a bit challenging. The new stores, it has been slow to get them rolled out, again, just because of the regulatory hurdles that we need to overcome.
We're very comfortable with the network that's in place now, and we're evaluating each and every store, you know, including all the legacy stores. We're doing a deep dive analysis to see which stores can be improved upon. We're also going to look at, you know, whether some of those, you know, we need to think about moving them out of the portfolio. A lot of things moving, but we're going in the right direction. Dennis, I'm going to pass to you on more technical details, Pablo's question.
Dennis Wilman (CFO)
Yeah, and Pablo, just, you know, focusing on the Florida capacity question, you know, the improvements we implemented in Florida were really meant to enhance product quality. As Bob mentioned, you know, we got caught last summer with, you know, greenhouse-grown flower in a very hot, humid environment. We saw, you know, THC testing levels drop substantially, as well as the quality of this overall flower decline way more than we anticipated. The new houses have rectified that. You know, while it's not premium indoor flower quality like we have in Nevada, it has vastly improved over what was there. We've had the second of the two houses that we upgraded that's come online. You know, I think we've got our first harvest off of it. During the yield analysis, as Bob mentioned, it's up substantially.
We have enough capacity to feed the existing store network, and we do have substantial excess biomass on hand that we're going to feed into our planned BHO lab that is in process. That's the one piece of CapEx that I mentioned in my comments on the call that we're still going ahead with. That will give us a full suite of products across our store network. Right now, we don't have the BHO concentrate products that all of our competitors do, and we're noticing, you know, patient demand for that in the Florida market. We would rather be a one-stop shop, give them quality flower that we're getting out of our newly revamped houses, as well as then have the BHO product categories in each of the stores to help, you know, draw customers into that one-stop shopping situation.
Hopefully hoping to have that BHO lab online this year towards the end of the year. If we can accelerate it, we will. We do have substantial biomass to start feeding through that. With the existing capacity, both unupgraded grow rooms and the upgraded grow houses that we have, we have more than enough to feed the store network that we have in Florida.
Pablo Zuanic (Managing Partner)
Right. Thank you. I mean, this is more a comment, maybe, you know, for you to comment on my comment. When we check the SKUs per store, right, the Florida stores have very few SKUs compared to other competing stores, right, from the competition. We are beginning to see the OMMU flower numbers for you improve significantly. That is being taken care of.
There is still a lot of room, however, on the non-flower side for all those extra products. From what you are saying, you see room to improve that in terms of SKUs later in the year. That is a good thing. Not in the short term at least in terms of non-flower products. Is that correct?
Dennis Wilman (CFO)
Yeah, that is correct. I mean, we do not have the, you know, Florida, as you know, is a fully vertical market. We do not have the capacity to go and buy or source non-flower SKUs in the categories that we do not have, as you point out. We are sort of in the short term, we are stuck with what we have.
We've done some analysis, you know, using the OMMU data on competing stores and have a pretty good idea as to what revenue we're missing on a per store basis annually from lack of those products available on our shelves. That should generate, you know, less than a 12-18 month payback on the CapEx expenses.
Pablo Zuanic (Managing Partner)
All right. Thank you. Then one for Larry. In terms of, you know, the focus on entertainment, the press release says continues to drive relative outperformance. That is good. Can you give an update in terms of where are we with Fight Club, the focus on the apparel strategy? What is happening with that? When we talk about entertainment, is it mostly these celebrity-type related events?
Larry Scheffler (Co-Chairman and Co-CEO)
We backed off a little bit of the Fight Club. We did not get as much success as we had hoped for. We are doing a lot of other things to drive more people in here and get awareness from the tourists before they even get here. We implemented about two weeks ago where if you are on TikTok, which is going crazy all over around here, if you do a video and show us why you come in, you get a free pre-roll. It costs us very little to do the pre-roll. We right now are getting 1,000 TikTok posts per week and increasing. That has been a huge success for us since all the younger generation are doing so much of the TikTok videos of what is going on. We are continuing to enhance that. We think it will be a big plus.
That's one of what we're trying to kind of think outside the box and do more guerrilla marketing, which we're doing. We're also implementing a lot of, I like to say, guerrilla marketing on the EDC, pushing a lot for our consumption lounge, where we're hoping to even have that maxed out over this weekend with EDC through different guerrilla marketing tactics and where we're actually approaching the people as you're getting out of the rideshare and so on and actually giving them a tour through the consumption lounge, even if the lounge is full. As long as they post a video again, they get a discount on there or another pre-roll.
We're also utilizing, and it just started today, utilizing that if they spend, customers coming in and getting a $20 tattoo from the tattoo parlor in here, and then they come into ours and spend at least $20 to get a free pre-roll. They think they can flood the market with that. There are several locations that are around Las Vegas. They are going to help us promote that free of charge, giving the coupons out to all their customers. Those are a few things we're doing again to drive the different things here in Vegas that we think are going to be a very big success.
Pablo Zuanic (Managing Partner)
Right. That's great. Because, I mean, historically, the superstore has catered more to tourists, right? Or it's been the bulk of the business has been with tourists. But you're saying that I don't know if you can track the numbers, but are you seeing, you know, a greater percentage of local buyers coming to the stores, to the superstores?
Larry Scheffler (Co-Chairman and Co-CEO)
No, it's still saying the same about 80-20 for 80% tours, just because of where we are. We want to capture more of the tourists that are coming to town. It's just so many that come in, and we'll stand and watch them even coming in the front door. If they're amazed, can't believe the floor, interactive floor they walk on, then they were here for the first time if they're that amazed with it. Otherwise, you walk across it and go inside the Planet 13. It's still a constant battle with the number of tourists around the world that come here. That's why we're trying to get more people aware of what's going on. We did a survey here the last few weeks, me and a couple of other people down by the tattoo parlor. Hey, what are you guys here for? Oh, tattoo.
How'd you hear about it? How'd you hear about the tattoo? Are you here to get cannabis? Are you going to shop for cannabis even though you're here? Every person that we've done a survey on for the tattoo parlor has been through TikTok. Every single one. We want to capture those people that maybe didn't come here to get a THC product or a clothing product and capture them through what I was just talking about with the coupon that the tattoo is going to help us with and capture some of those people too. There's a lot coming in and leaving on that. It's low-hanging fruit that we think we're able to bring in and turn into basket sizes.
Pablo Zuanic (Managing Partner)
That's great. Thank you. That's all.
Operator (participant)
We'll hear next from Paul Penny, Partner Capital Group.
Paul Penny (Managing Director)
Hey, gentlemen. Any updates on the regulatory environment in Nevada, specifically on any efforts to curtail the hemp-derived THC products that seem to be increasingly prevalent and readily available on the strip?
Bob Groesbeck (Co-Chairman and Co-CEO)
Yeah. Hey, Paul, it's Bob. You know, our session, of course, our legislature is in session now. Things are really kind of heating up. They've just got three weeks left, I believe. Initially, there wasn't really any significant language that we thought would rein this in. Then we did see a couple of bills that died, actually, were resurrected with some pretty significant hemp language. Again, we're monitoring that. We're going to just see where things go. My gut tells me that there's not an appetite to get a comprehensive bill passed this session, similar to what we just saw happen in Florida. You know, we're hopeful that, you know, there will be something on the books and there will be some regulatory oversight. Again, you know, it's crazy up there.
As they get into the 11th hour, it's difficult to really gauge how things go until they actually pass out or fail.
Paul Penny (Managing Director)
Fair enough. There has been a little bit in Arizona, a little bit of a change there, a regulatory change that's helped the last couple of weeks. I'm sure you're watching that as well. Changing gears.
Bob Groesbeck (Co-Chairman and Co-CEO)
All the help we can get, rather.
Paul Penny (Managing Director)
Exactly. Just one quick one. When you look at potential cost-cutting efforts going forward, can you maybe first rank maybe the two to three biggest focus areas? Is there an aspirational operating margin or gross margin you guys are trying to back into?
Dennis Wilman (CFO)
Yeah, Paul, it's Dennis. We've always talked about maintaining a 50%+ gross margin percentage across the retail network and higher in Nevada, where we have vertical integration and sort of more control over that market environment. The cuts that we are making are both on the cultivation side, controlling those costs. Obviously, it's mostly labor that we can control. There are a lot of fixed costs in those operations. The same thing on the production side of the equation. At the retail level, consolidating stores in the network to have one general manager run more than one store kind of thing.
Kind of optimizing revenue per employee at the retail end of the equation and maximizing yield per employee on the cultivation production side of it. That's sort of the core focus, as well as reducing the non-cannabis that's being incorporated overhead costs. Kind of looking at everything from, you know, getting concessions on our professional fees and audit fees and tax fees to, you know, everything in between.
Paul Penny (Managing Director)
Perfect. Thanks, guys. Appreciate it.
Operator (participant)
At this time, there are no further questions. Ladies and gentlemen, that does conclude our conference for today. We would like to thank you all for your participation. You may now disconnect.